{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:49:34Z","timestamp":1774529374440,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.purol.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T18:42:16Z","timestamp":1536864136000},"page":"868-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prise en charge de l\u2019obstacle sous v\u00e9sical li\u00e9 \u00e0 une HBP chez les patients \u00e0 terrain particulier et\/ou ayant une complication"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Descazeaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"de La Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2018.08.006_bib0255","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000474208","article-title":"Transurethral prostatectomy: a long-term follow-up study of 166\u00a0patients over 80\u00a0years of age","volume":"30","author":"Matani","year":"1996","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.08.006_bib0260","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/bju.12063","article-title":"Age-stratied outcomes of holmium laser enucleation of the prostate","volume":"112","author":"Mmeje","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2018.08.006_bib0265","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.6061\/clinics\/2012(12)11","article-title":"Standard surgical treatment for benign prostatic hyperplasia is safe for pa- tients over 75\u00a0years: analysis of 100\u00a0cases from a high-volume uro-logic center","volume":"67","author":"Marmiroli","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.purol.2018.08.006_bib0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/B:UROL.0000032683.36827.63","article-title":"Are indications for prostatectomy in octogenarians the same as for younger men?","volume":"36","author":"Nadu","year":"2004","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.purol.2018.08.006_bib0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5213\/inj.1630478.239","article-title":"Holmium laser enucleation of the prostate is safe for patients above 80\u00a0years: a prospective study","volume":"20","author":"Piao","year":"2016","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.purol.2018.08.006_bib0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-13-12","article-title":"Impact of type 2\u00a0diabetes on lower urinary tract symptoms in men: a cohort study","volume":"13","author":"Van Den Eeden","year":"2013","journal-title":"BMC Urol"},{"issue":"4","key":"10.1016\/j.purol.2018.08.006_bib0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11934-009-0044-5","article-title":"Diabetes and benign prostatic hyperplasia: emerging clinical connections","volume":"10","author":"Sarma","year":"2009","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.purol.2018.08.006_bib0290","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.urology.2014.04.027","article-title":"Factors associated with continuing medical therapy after transurethral resection of prostate","volume":"84","author":"Han","year":"2014","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.purol.2018.08.006_bib0295","first-page":"109","article-title":"Long-term outcome of trans urethral prostatectomy in benign prostatic hyperplasia patients with and without diabetes mellitus","volume":"60","author":"Soleimani","year":"2010","journal-title":"J Pak Med Assoc"},{"issue":"9","key":"10.1016\/j.purol.2018.08.006_bib0300","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1046\/j.1464-410x.1999.00075.x","article-title":"Thrombotic risk factors associated with transurethral prostatectomy","volume":"83","author":"Bell","year":"1999","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.purol.2018.08.006_bib0305","first-page":"e123","article-title":"2016\u00a0ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.purol.2018.08.006_bib0310","unstructured":"Gravas S, Cornu JN, Drake M, Gacci M, Gratzke C, Herrmann T, Madersbacher S, Mamoulakis C, Tikkinen K, EAU Guidelines 2018\u00a0on Non Male LUTS.(Uroweb.org)."},{"issue":"10","key":"10.1016\/j.purol.2018.08.006_bib0315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11934-017-0727-2","article-title":"Holmium Laser Enucleation of the Prostate in Patients Requiring Anticoagulation","volume":"18","author":"Rivera","year":"2017","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.purol.2018.08.006_bib0320","series-title":"Antiagr\u00e9gants plaquettaires\u00a0: prise en compte des risques thrombotique et h\u00e9morragique lors d\u2019une intervention endoscopique urologique chez le coronarien","author":"HAS","year":"2012"},{"issue":"1","key":"10.1016\/j.purol.2018.08.006_bib0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOU.0b013e32835ac039","article-title":"Bladder outlet procedures in the setting of anticoagulation therapy","volume":"23","author":"Marien","year":"2013","journal-title":"Curr Opin Urol"},{"issue":"15","key":"10.1016\/j.purol.2018.08.006_bib0330","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.purol.2016.09.053","article-title":"Troubles du bas appareil urinaire et de la statique pelvienne chez les candidats et receveurs d\u2019une transplantation r\u00e9nale","volume":"26","author":"Thuret","year":"2016","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2018.08.006_bib0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/00365599.2011.633225","article-title":"Predictive factors for urinary retention following kidney transplantation in male patients","volume":"46","author":"Gratzke","year":"2012","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.purol.2018.08.006_bib0340","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1166-7087(07)92363-5","article-title":"Hypertrophie b\u00e9nigne de la prostate et neuro-urologie","volume":"17","author":"Chartier Kastler","year":"2007","journal-title":"Prog Urol"},{"issue":"5","key":"10.1016\/j.purol.2018.08.006_bib0345","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/nau.22764","article-title":"Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders","volume":"35","author":"Sakakibara","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2018.08.006_bib0350","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","article-title":"Complications of transurethral resection of the prostate (TURP) incidence, management, and prevention","volume":"50","author":"Rassweiler","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2018.08.006_bib0355","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/nau.22222","article-title":"Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011","volume":"31","author":"Oelke","year":"2012","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.purol.2018.08.006_bib0360","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.urology.2014.06.038","article-title":"Intravesical prostatic protrusion is a risk factor for bladder stone in patients with benign prostatic hyperplasia","volume":"84","author":"Kim","year":"2014","journal-title":"Urology"},{"issue":"32","key":"10.1016\/j.purol.2018.08.006_bib0365","doi-asserted-by":"crossref","first-page":"e7728","DOI":"10.1097\/MD.0000000000007728","article-title":"Risk factors for bladder calculi in patients with benign prostatic hyperplasia","volume":"96","author":"Huang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.purol.2018.08.006_bib0370","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0090-4295(91)80293-G","article-title":"Predisposing factors in bladder calculi. Review of 100\u00a0cases","volume":"37","author":"Douenias","year":"1991","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.purol.2018.08.006_bib0375","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.juro.2012.11.079","article-title":"Pathogenesis of bladder calculi in the presence of urinary stasis","volume":"189","author":"Childs","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.08.006_bib0380","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.purol.2018.08.006_bib0385","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.purol.2012.10.001","article-title":"Bilan initial, suivi et traitement des troubles mictionnels li\u00e9s \u00e0 une hyperplasie b\u00e9nigne de prostate\u00a0; recom-mandations du CTMH de l\u2019AFU","volume":"22","author":"Descazeaud","year":"2012","journal-title":"Prog Urol"},{"issue":"5","key":"10.1016\/j.purol.2018.08.006_bib0390","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2018.08.006_bib0395","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.urology.2015.04.022","article-title":"Conservative treatment for benign prostatic hyperplasia in patients with bladder stones","volume":"86","author":"Yoshida","year":"2015","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.purol.2018.08.006_bib0400","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0090-4295(02)01698-9","article-title":"Nonsurgical management of benign prostatic hyperplasia in men with bladder calculi","volume":"60","author":"O\u2019Connor","year":"2002","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.purol.2018.08.006_bib0405","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1464-410X.2012.11101.x","article-title":"Chronic urinary retention in men: how we define it, and how does it affect treatment outcome","volume":"110","author":"Negro","year":"2012","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.purol.2018.08.006_bib0410","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","article-title":"EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction","volume":"67","author":"Gratzke","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2018.08.006_bib0415","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0022-5347(05)00708-1","article-title":"Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo","volume":"175","author":"Crawford","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2018.08.006_bib0420","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.pcan.4500827","article-title":"Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms\/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise","volume":"8","author":"Speakman","year":"2005","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"25","key":"10.1016\/j.purol.2018.08.006_bib0425","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.purol.2018.08.006_bib0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169248","article-title":"Efficacy and safety of initial combination treatment of an alpha blocker with an anticholinergic medication in benign prostatic hyperplasia patients with lower urinary tract symptoms: updated meta-analysis","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.purol.2018.08.006_bib0435","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM199501123320202","article-title":"A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The veterans affairs cooperative study group on transurethral resection of the prostate","volume":"332","author":"Wasson","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.purol.2018.08.006_bib0440","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00345-011-0725-9","article-title":"Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder","volume":"30","author":"Heyns","year":"2012","journal-title":"World J Urol"},{"issue":"7","key":"10.1016\/j.purol.2018.08.006_bib0445","first-page":"641","article-title":"[Urodynamics of the bladder diverticulum in the adult male]","volume":"58","author":"Adot Zurbano","year":"2005","journal-title":"Arch Esp Urol"},{"issue":"4","key":"10.1016\/j.purol.2018.08.006_bib0450","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1590\/s1677-5538.ibju.2017.0605","article-title":"The role of bladder diverticula in the prevalence of acute urinary retention in patients with BPH who are candidates to surgery","volume":"44","author":"Iscaife","year":"2018","journal-title":"Int Braz J Urol"},{"issue":"5","key":"10.1016\/j.purol.2018.08.006_bib0455","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1089\/end.2006.20.346","article-title":"Sequential holmium laser enucleation of the prostate and laparoscopic extraperitoneal bladder diverticulectomy: initial experience and review of literature","volume":"20","author":"Shah","year":"2006","journal-title":"J Endourol"},{"issue":"6","key":"10.1016\/j.purol.2018.08.006_bib0460","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/end.1996.10.545","article-title":"Sequential laparoscopic bladder diverticulectomy and transurethral resection of the prostate","volume":"10","author":"Iselin","year":"1996","journal-title":"J Endourol"},{"issue":"1","key":"10.1016\/j.purol.2018.08.006_bib0465","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00345-017-2114-5","article-title":"Holmium laser enucleation of the prostate is an effective treatment in patients with concomitant bladder diverticula and outlet obstruction","volume":"36","author":"Agarwal","year":"2018","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.purol.2018.08.006_bib0470","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1464-410X.2003.04444.x","article-title":"Is the conservative management of chronic retention in men ever justified?","volume":"92","author":"Bates","year":"2003","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.purol.2018.08.006_bib0475","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1523-1755.2005.00344.x","article-title":"The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men","volume":"67","author":"Rule","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.purol.2018.08.006_bib0480","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0090-4295(97)00614-6","article-title":"Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up","volume":"51","author":"Miller","year":"1998","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2018.08.006_bib0485","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bju.13524","article-title":"Role of prostate artery embolization in the management of refractory haematuria of prostatic origin","volume":"118","author":"Pereira","year":"2016","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.purol.2018.08.006_bib0490","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.juro.2013.03.070","article-title":"Risk factors for delayed hematuria following photoselective vaporization of the prostate","volume":"190","author":"Jackson","year":"2013","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2018.08.006_bib0495","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/pros.20846","article-title":"Prevalence of and risk factors for prostatitis in African American men: the Flint Men's Health Study","volume":"69","author":"Wallner","year":"2009","journal-title":"Prostate"},{"issue":"25","key":"10.1016\/j.purol.2018.08.006_bib0250","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718304718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718304718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:31:01Z","timestamp":1761114661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708718304718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1166708718304718"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2018.08.006","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge de l\u2019obstacle sous v\u00e9sical li\u00e9 \u00e0 une HBP chez les patients \u00e0 terrain particulier et\/ou ayant une complication","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}